Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Thrombectomy, IVC filters & venous stents · Massachusetts | Thrombectomy, IVC filters & venous stents · New York | |
|---|---|---|
| Surgeons, 2024 | 2 | 24 |
| Medicare fee-for-service cases | 738 | 2,696 |
| Growth since 2019 (Medicare FFS) | −0.4%/yr | −2.3%/yr |
| Forecast cases (Medicare FFS) | 740 in 2030 | 3,720 in 2030 |
| Forecast growth | +0.1%/yr to 2030 | +5.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.8 | 1.5 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 9% (+9 pts since 2019) | 17% (−5 pts since 2019) |
| Cases per surgeon | 369 | 112 |
| Top 10 surgeons' share | 100% | 58% |
| Surgeons growing | 0 | 0 |
| New since the base year | 0 | 6 |
| Likely to stop billing it | 2 by 2026 | 16 by 2026 |
| Forecast miss, 1 year (procedure) | 9% | 9% |
| Company payments per surgeon | $155K | $45K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.